Paracoccidioidomycosis: Causes, Symptoms, and Treatment

Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by the Paracoccidioides species, primarily Paracoccidioides brasiliensis and Paracoccidioides lutzii. It is prevalent in rural areas of Latin America, particularly where agricultural activities occur. Known also as South American Blastomycosis, PCM is a chronic granulomatous disease that primarily affects the lungs but can spread to other organs like the skin, mucous membranes, lymph nodes, and adrenal glands.

It is more common in men, with a male-to-female ratio of about 15:1, likely due to estrogen’s protective effects against the fungus. Understanding the symptoms, causes, diagnosis, and treatment options is essential for managing and controlling this potentially debilitating disease.

What are the different Types of Paracoccidioidomycosis?

Paracoccidioidomycosis has two main types:

Acute/Subacute (Juvenile) Form: Affects children and young adults, spreading to lymph nodes, liver, and spleen. Symptoms include fever, weight loss, and swollen lymph nodes.
Chronic (Adult) Form: Common in adult males, mainly affecting the lungs, skin, and mucous membranes. Symptoms include chronic cough, breathing issues, and oral lesions.

What are the Causes of Paracoccidioidomycosis?

Etiological Agents

Paracoccidioidomycosis is caused by the dimorphic fungi Paracoccidioides brasiliensis and Paracoccidioides lutzii. These fungi exist as moulds in the environment and transform into yeast forms within the human body. The infection occurs when individuals inhale the fungal spores present in the soil.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Risk Factors

Risk factors for paracoccidioidomycosis include:

Occupational Exposure: Individuals involved in farming, mining, and other activities that disturb the soil are at higher risk.
Geographical Location: The disease is endemic in countries like Brazil, Argentina, Colombia, and Venezuela.
Immunosuppression: Individuals with weakened immune systems are more susceptible to severe forms of the disease.

What are the Symptoms of Paracoccidioidomycosis?

Acute/Subacute Form

The acute or subacute form of paracoccidioidomycosis, also known as juvenile-type PCM, is less common and predominantly affects individuals under 30 years of age. Symptoms include:

Fever: Persistent high fever is common.
Lymphadenopathy: Enlarged lymph nodes, especially in the cervical and axillary regions.
Hepatosplenomegaly: Enlargement of the liver and spleen.
Skin Lesions: Painful ulcerative lesions on the skin and mucous membranes.

Chronic Form

The chronic form, also known as adult-type PCM, is more prevalent and affects individuals over 30 years old. Symptoms include:

Respiratory Symptoms: Chronic cough, expectoration, and dyspnea (shortness of breath).
Weight Loss: Significant weight loss and cachexia.
Mucosal Lesions: Ulcerative lesions in the mouth, nose, and throat.
Skin Lesions: Verrucous or ulcerative skin lesions.

How is Paracoccidioidomycosis Diagnosed?

Clinical Evaluation

Diagnosis begins with a thorough clinical evaluation, including a detailed medical history and physical examination. The presence of characteristic symptoms and risk factors can aid in clinical suspicion.

Laboratory Tests

Microscopy and Culture: Direct microscopy of clinical specimens (sputum, pus, or tissue biopsies) can reveal the presence of the characteristic yeast forms of Paracoccidioides. Culturing the fungus confirms the diagnosis.
Serological Tests: Detection of specific antibodies against Paracoccidioides antigens in the patient's blood can support the diagnosis.
Molecular Methods: Polymerase chain reaction (PCR) assays can detect fungal DNA in clinical samples.

What are the Treatment Options for Paracoccidioidomycosis?

Antifungal Therapy

Treatment for paracoccidioidomycosis primarily involves prolonged antifungal therapy. The choice of antifungal agent depends on the severity of the disease and the patient's overall health.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Itraconazole: This triazole antifungal is the first-line treatment for both acute and chronic forms of PCM. The usual treatment duration is 6 to 12 months.
Amphotericin B: Used for severe or disseminated cases, particularly in immunocompromised patients. It is administered intravenously until clinical improvement is observed, followed by oral itraconazole.
Trimethoprim-Sulfamethoxazole (TMP-SMX): An alternative treatment option, especially in resource-limited settings. The treatment duration is typically longer, often exceeding one year.

Supportive Care

Nutritional Support: Patients with significant weight loss may require nutritional supplementation.
Management of Complications: Addressing complications such as respiratory failure, adrenal insufficiency, and secondary infect ions is crucial for patient recovery.

How can Paracoccidioidomycosis be Prevented?

Preventing paracoccidioidomycosis involves minimizing exposure to the fungal spores. This can be challenging in endemic regions, but certain measures can help reduce the risk:

Use of Protective Equipment: Wear masks and protective clothing during activities that disturb the soil.
Environmental Control: Implementing measures to reduce dust and soil aerosolization in agricultural and construction sites.
Health Education: Educating at-risk populations about the disease, its risk factors, and prevention strategies.

Find Our Specialists

Book Doctor Appointment

Name*

Mobile Number*

I agree to the Medicover Privacy Policy

International Patient Services

Still have questions? Speak with our experts now!

040-68334455

Frequently Asked Questions

The duration of paracoccidioidomycosis (PCM) can vary depending on the severity and treatment. With appropriate antifungal therapy, the acute form may improve within a few months, while chronic cases could last longer. The course of the disease is also influenced by the patient's immune response and how early the infection is detected and treated. Untreated PCM can persist for years and may worsen over time.

The drug of choice for treating Paracoccidioides, the fungus responsible for paracoccidioidomycosis, is itraconazole. For more severe or resistant cases, amphotericin B may be used initially to control the infection, followed by long-term itraconazole therapy. Treatment duration can range from several months to a year, depending on the case severity and response to medication.

Yes, paracoccidioidomycosis can affect organs other than the lungs. While it typically starts in the lungs, it can spread to other parts of the body, including the skin, mouth, liver, and lymph nodes. In some cases, it can cause chronic or disseminated disease affecting multiple organs, leading to serious complications if left untreated.

No, paracoccidioidomycosis is not contagious. It is a fungal infection acquired primarily through inhalation of fungal spores found in the soil of endemic regions, particularly in parts of Latin America. The infection does not spread through human-to-human contact. However, individuals in endemic areas are at greater risk due to exposure to the spores.

Yes, paracoccidioidomycosis can cause permanent damage if not treated promptly or effectively. Chronic cases can lead to lung scarring, chronic respiratory issues, or organ damage in more severe forms. Delayed treatment or recurrent infections can lead to long-term health issues, making early diagnosis and proper antifungal treatment crucial to minimize lasting effects.